Long-term treatment of girls with ornithine transcarbamylase deficiency

New England Journal of Medicine

Volumn 335, Issue 12, 1996, Pages 855-859

  Maestri, Nancy E ^a,b   Brusilow, Saul W ^a   Clissold, David B ^a   Bassett, Susan S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORNITHINE CARBAMOYLTRANSFERASE;

ADOLESCENT; ARTICLE; BODY WEIGHT; BRAIN DISEASE; CHILD; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE DEVELOPMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; HETEROZYGOSITY; HUMAN; HYPERAMMONEMIA; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; METABOLIC ENCEPHALOPATHY; NITROGEN URINE LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL;

ADOLESCENT; AMINO ACID METABOLISM, INBORN ERRORS; AMMONIA; BENZOATES; BENZOIC ACID; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INTELLIGENCE; ORNITHINE CARBAMOYLTRANSFERASE; PHENYLACETATES; PHENYLBUTYRATES; TREATMENT OUTCOME;

EID: 0029786498     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609193351204     Document Type: Article

References (14)

1. Msall M, Batshaw ML, Suss R, Brusilow SW, Mellits ED. Neurologic outcome in children with inborn errors of urea synthesis: outcome of ureacycle enzymopathics. N Engl J Med 1984;310:1500-5.
2. Brusilow SW. Urea cycle disorders: clinical paradigm of hyperammonemic encephalopathy. In: Boyer JL, Ockncr RK, eds. Progress in liver disease. Vol. 13. Philadelphia: W.B. Saunders, 1995:293-309.
3. Finkelstein JE, Hauser ER, Leonard CO, Brusilow SW. Late-onset or nithine transcarbamylase deficiency in male patients. J Pediatr 1990;117: 897-902. [Erratum, J Pediatr 1991;118:326.]
4. Batshaw ML, Roan Y, Jung AL, Rosenberg LA, Brusilow SW. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency. N Engl J Med 1980;302:482-5.
5. Rowe PC, Newman SL, Brusilow SW. Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 1986;314: 541-7.
6. Brusilow SW, Finkelstein JE. Restoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency. Metabolism 1993;42: 1336-9.
7. Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr 1996;43:127-70.
8. Brusilow SW, Danney M, Waber LJ, et al. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. N Engl J Med 1984;310:1630-4.
9. Sullivan KM, Gorstein J. ANTHRO: software for calculation of pediatric anthropometry, version 1.01. Atlanta: Centers for Disease Control, 1990 (software and manual).
10. Dibley MJ, Goldsby JB, Staehling NW, Trowbridge FL. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 1987;46:736-48.
11. Maestri NE, Clissold DB, Brusilow SW. Long-term survival of patients with argininosuccinate synthetase deficiency. J Pediatr 1995;127:929-35.
12. Batshaw ML, Msall M, Beaudet AL, Trojak J. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr 1986; 108:236-41.
13. Sattler JM. Assessment of children revised and updated. 3rd ed. San Diego: JM Sattler, 1992.
14. Wechsler D. Manual for the Wechsler Intelligence Scale for Children. 3rd ed. San Antonio, Tex.: Psychological Corporation, 1991.